Background/Objectives: Body mass index (BMI), waist circumference (WC), body weight modification, and rate of weight increase over 10 years were evaluated in relation to high-sensitive C-reactive protein (hs-CRP) to assess the association of cross-sectional or longitudinal estimates of obesity/overweight with levels of circulating CRP, a well established and standardized marker of low-grade inflammation, in relation to cardiovascular risk. Subjects: This study included a subgroup of 390 menopausal women participating in a large currently ongoing epidemiological study (Progetto Atena; N ¼ 5062). Results: At the final visit, women in the third tertile of BMI, compared with those in the first tertile, showed the following odds ratio (OR) of having high hs-CRP values: III vs I tertile OR, 3.55; 95% confidence interval, 1.94-6.49, Po0.001, adjusted for age, and metabolic syndrome. Similar results were obtained when we evaluated women in the third tertile of WC, or those in the highest group of estimated weight increase, relative to their weight at age 20 years or in the group of highest rate of weight increase over 10 years of observation (weight at the final visitÀweight at the baseline visit divided by time in months between visits). Conclusions: The independent relations between different markers of overweight/obesity and elevated hs-CRP consistently indicate that high (above 1.5 mg l -1 , median) hs-CRP is a major biochemical counterpart of cross-sectional or longitudinal estimates of increased adipose tissue mass.
Introduction
The prevalence of overweight and obesity is sharply rising in the general population in developed country and has received increased attention in the past few years. Obesity is associated with increased risk of developing coronary heart disease, stroke, hypertension, type 2 diabetes, and dyslipidemia (Wannamethee et al., 2005; Pérez Pérez et al., 2007) . Recently, low-grade inflammation has been considered as a possible new risk factor (Ridker, 2007) associated with obesity and visceral adiposity (Scherer, 2006) . Traditional cardiovascular risk factors such as central obesity, high blood pressure, and insulin resistance, especially if components of the metabolic syndrome (MS) have been associated with increased levels of C-reactive protein (CRP), are a marker of low-grade inflammation that may have a major function in the pathogenesis of cardiovascular diseases (Ridker, 2007) . Worldwide change in dietary patterns (increasing calorie intake especially from animal fat), together with sedentary lifestyle, has produced high prevalence of overweight, obesity, glucose intolerance, and diabetes particularly in women.
Although weight loss may be an effective non-pharmacologic strategy for lowering CRP (Selvin et al., 2007) , it is uncertain whether the extent to which an increase in body weight is a predictor of systematic inflammation during a long-term period. To our knowledge, there are no large prospective studies of the association between body weight change and its relation to changes in systemic inflammation in samples representative of a general adult population.
The aim of the present analysis, performed in a population-based sample of middle-aged women, free-living in the southern Italy and participating in Progetto Atena, was to evaluate the association of cross-sectional or longitudinal estimates of obesity/overweight and the levels of circulating CRP, a well established and standardized marker of low-grade inflammation, in relation to cardiovascular risk.
Materials and methods

Study population
The Progetto Atena was carried out on 5062 women aged 30-69 years living in the area of Naples (southern Italy) (Panico et al., 1992) . The main purpose of this study was to investigate the causes of the chronic diseases that have a major impact on the female population. Potential participants with earlier diagnoses of myocardial infarction, stroke, and major cancers were excluded at the baseline visit. During a 6-month period, the older three of 10 daily participants, considered at potentially higher risk of atherosclerotic cardiovascular disease, were invited to undergo an ultrasound examination of the carotid arteries and additional biochemical tests. The same women (n ¼ 400) were recalled after a period of 10 years of follow-up (final visit). Of these, 390 accepted to participate, and all were post-menopausal. Several anthropometric and biochemical investigations were performed. The study was restricted to menopausal women to have a more homogeneous population at relatively higher risk of cardiovascular disease.
Blood samples were taken for biochemical analysis including high-sensitive CRP (hs-CRP). All women gave their written informed consent, and the study was approved by the ethical committees of the institutions involved.
Clinical and biochemical assessment Body mass index (BMI), used as a general measure of obesity, was calculated at the final visit as weight (kilograms) divided by height (meters squared). Waist circumference (WC), an index of abdominal obesity, was measured midway between the bottom of the rib cage and the top of the iliac crest (Klipstein-Grobusch et al., 1997) .
Weight modification over adult life (D weight) was calculated in comparison with weight reported at 20 years of age with the following formula: D weight ¼ weight at the final visitÀweight at 20 age years. Weight at 20 years of age was assessed on the basis of a questionnaire (Panico et al., 1992) .
Rate of weight modification between the baseline visit and the final visit, during 10-year observation period, was calculated with the following formula: D weight between final visit and baseline visit (weight at final visitÀweight at baseline visit) divided by time in months between the visits.
Sitting brachial blood pressure was measured twice at least after 5 min rest using a random-zero sphygmomanometer.
The American Heart Association Scientific Statement criteria (Grundy et al., 2005) were used to classify women as having the MS on the basis of the presence of X3 of the following risk factors: (1) WC 488 cm, (2) fasting triglycerides X150 mg per 100 ml, (3) high-density lipoprotein (HDL) cholesterol o50 mg per 100 ml, (4) hypertension (systolic blood pressure X130 mm Hg or diastolic blood pressure X85 mm Hg), and (5) fasting glucose X100 mg per 100 ml. Anthropometric measurements were made with the subjects in indoor clothing and without shoes.
Blood specimens were collected after a 12-to 14-h fast, from 0800 to 0930 hours, to reduce the influence of circadian variation. Total cholesterol and triglyceride concentrations were measured using standard enzymatic methods (Wahlefeld, 1974; Siedel et al., 1981) ; HDL was measured after the precipitation of very-low-density lipoproteins and lowdensity lipoproteins with phosphotungstic acid (Lopes-Virella et al, 1977) ; low-density lipoprotein cholesterol was calculated according to the Friedewald formula. Fasting glucose levels were enzymatically determined by the peroxidase method. Fasting insulin levels were determined by enzyme immunoassay (Ultrasensitive Insulin Elisa, Mercodia, Sweden). Apolipoprotein B and hs-CRP were measured with turbidimetric assay, using automated methods (Cobas-Mira, Roche, Italy). The error of the method was evaluated daily by analyzing a plasma pool and was o5%. The homeostatic assessment model (HOMA) index was used to estimate insulin resistance and calculated as fasting serum insulin (mU ml -1 ) Â fasting serum glucose (mM)/22.5, as described by Matthews et al. (1985) . Total cholesterol, triglycerides, HDL, glucose, and insulin were measured at baseline and the final visit, whereas Apo B and hs-CRP only at final visit.
Statistical analyses
Statistical analyses were performed using SPSS version 11.0 (SPSS, Inc., Chicago, Illinois, USA). Continuous variables were described as mean and standard deviation and the analysis of covariance was used to obtain age-adjusted means of physical and biochemical variables. Variables that were not normally distributed were evaluated by Spearman's rank correlation or were logarithmically transformed before multivariate linear analysis. Logistic multivariate regression analysis was used to test the independent relation between hs-CRP (above median level 1.5 mg l -1 ) (dependent variable) and age, triglycerides, LDL cholesterol, HDL cholesterol, apo B, HOMA index, systolic pressure (PAS), BMI, BMI tertiles, WC, WC tertiles, weight modification (D weight) in comparison with weight reported at 20 years of age, and rate of weight modification between the final and baseline visits (independent variables). Odds ratio (OR) for the presence of high hs-CRP (above 1.5 mg l -1 , median of Obesity and weight gain in Mediterranean women M Gentile et al the distribution) was calculated by unconditional logistic binary regression and 95% confidence intervals were computed for the standard error of the regression coefficient.
Significance was inferred at Po0.05.
Results
Cardiovascular risk profile of the Progetto Atena study population at the age of recruitment (1992) (1993) (1994) (1995) (1996) ; n ¼ 5062), including the subsample in which hs-CRP was determined (N ¼ 390) and the remaining cohort (N ¼ 4672), is shown in Table 1 . After adjustment for age, there were no significant differences in cardiovascular risk profile between the subsample and the remaining cohort. More details on physical and biochemical characteristics of the study participants are shown in Table 2 . The prevalence of overweight/obesity, according to WHO classification in the population studied, was 71%. Women with weight at age 20 years in the upper tertile (as estimated from the questionnaire) had an OR of having weight in the upper tertile at the final visit of 3.58 (Po0.0001) after adjustment for the number of years between age 20 years and the final observation. Out of the 390 participants at the final visit, 157 (40.6%) had the MS. At the final visit, hs-CRP was significantly correlated with weight (in kg), BMI, and WC, Rho of Spearman (0.272, Po0.001) (0.275, Po0.001) (0.223, Po0.001), respectively. Women with CRP above the median level (1.5 mg l -1 ) were overweight or obese according to WHO criteria in 78.2% of cases. We evaluated, in a multivariate logistic analysis, the association between BMI or WC, and hs-CRP, taking into account different adjustment models (Table 3) In a subsequent analysis, we evaluated the association between rate of weight modification over 10 years, between the baseline and final visits and increased hs-CRP at the final visit (above 1.5 mg l -1 , median of the distribution), taking into account different adjustment models (Table 4) . Women in the group with highest rate of weight modification had an OR of 1.90, of having high hs-CPR values (above 1.5 mg l -1 ) at the final visit compared with those in the group with lowest rate of weight change, adjusted for age, and presence of MS.
Similar OR were obtained when the models included age and LDL, HDL or age, apo B, TG, or age, HOMA or age, PAS (data not shown). Rate of weight modification group cutoffs in our population were group I ¼ rate D weight o0 kg per month (range À0.16 to 0 kg per month); group II ¼ rate D weight 0-0.03 kg per month; group III ¼ rate D weight 0.03-0.06 kg per month; and group IV ¼ rate D weight 40.06 kg per month (range 0.06-0.27 kg per month).
Discussion
This study was carried out in a geographical area in which carbohydrate intake is still high despite changes in dietary pattern (increasing calorie intake and increasing intake of animal fat). The current diet together with sedentary habits have led to a high prevalence of overweight and obesity especially in women (Beer-Borst et al., 2000) .
High prevalence of subjects with overweight or obesity (42.0 and 29.0%, respectively) has been confirmed. This high rate, found for women living in a Mediterranean area, is similar to that in other studies conducted in southern Italy (Barbagallo et al., 2001) , and consistent with earlier finding in other European countries (Fry and Finley, 2005) .
Our data confirm that hs-CRP concentrations are higher in obese/overweight than in non-obese individuals (crosssectional examination). In obese individuals, obesity measured by BMI and WC was independently correlated with CRP concentration in multivariate analysis. In addition, new longitudinal variables, weight increase over 20 years, and rate of weight increase were all associated with CRP levels (above 1.5 mg l -1 ). These results may be related to the fact that adipose tissue is a dynamic endocrine organ involved in signalling pathways that contribute to the systemic inflammation cascade (Castell et al., 1990; Fried et al., 1998; Mohamed-Ali et al., 1998; Papanicolaou et al., 1998; Kern et al., 2001) .
Multivariate logistic regression analysis showed a significant relationship between BMI and WC with high hs-CRP values (above 1.5 mg l -1 ), which was independent of the presence of MS. 
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Emerging laboratory and epidemiological data now link high-sensitivity CRP to insulin resistance and adiposity and other features of MS. Furthermore, in large prospective studies, increased high-sensitivity CRP levels in MS confer greater cardiovascular risk (Mohamed-Ali et al., 1998) . We showed that the association of adiposity or weight change with high CRP were independent of MS. CRP may be an important marker of adipopathy (chronic inflammatory disease of adipose tissue) (Oda, 2008) .
In particular, we showed that a weight gain of at least 14 kg (III group) in comparison with weight reported at 20 years of age was associated with hs-CPR above the median. Women with a weight increase of o14 kg did not have hs-CRP above the median. Potentially, a relatively more rapid weight gain produce more inflammation in the adipose tissue. However, in our study, the rate of weight increase was weakly associated with high hs-CRP, and was not a strong predictor of increased CRP. No large prospective studies have evaluated the association between weight increase and systemic inflammation in samples representative of a general adult population. We now provide figures on the kg of weight increase in women, during adult life associated with lowgrade inflammation. Other studies (Haffner, 2007; Devaraj et al., 2009) have reported that lifestyle changes, including regular exercise training in overweight and obese adults, decreased hs-CRP, and this was associated with weight loss. The results of a systematic review suggested that for each 1 kg of weight loss, the mean change in CRP level was À0.13 mg l -1 (Selvin et al., 2007) . Another recent study (Hamer and Steptoe, 2009 ) indicated that markers of inflammation after 3 years of follow-up were associated with adiposity and not physical fitness; however, these data suggest independent anti-inflammatory effects of fitness in overweight and obese participants. A number of cytokines decreased after weight loss and rosiglitazone treatment, as did hs-CRP, one of the hepaticderived acute-phase reactants stimulated by inflammation (Mohanty et al., 2004; Okita et al., 2004; Koh et al., 2005) . Obesity, particularly in association with high WC and high BMI, is an independent risk factor for coronary heart disease and diabetes (Haffner, 2006) . In our set-up of primary prevention, women with hs-CRP value above median were overweight or obese, according to WHO criteria, in 78.2% of cases. Baseline findings in a Randomized Placebo Controlled Primary Prevention Trial showed that a population randomized (N ¼ 17802) in 26 countries on 4 continents, including North and South America, Europe, and Africa, and defined on the basis of the absence of traditional risk factor and hs-CRP above 2.0 mg l -1 had an average BMI in the range of overweight according to WHO . Several studies showed that marginal to moderate weight gain in adulthood (age 20-50 years) increase the risk of chronic disease and negatively affect coronary heart disease risk status (Walker et al., 1995; Rosengren et al., 1999; Wannamethee and Shaper, 1999; Wannamethee et al., 2005) . Our data show a highly consistent relationship between different markers of adipose mass (BMI, WC, weight increase compared with 20 years of age, and rate of weight gain) with chronic and low-grade inflammation, as detected by hs-CRP. Thus, when estimating cardiovascular risk, high hs-CRP represents a major biochemical counterpart of different cross-sectional and longitudinal estimates of adipose tissue mass.
